Atlantic International Corp.
NASDAQ:ATLNMedical - Diagnostics & Research
-$0.10 today
- Market cap
- $73.17M
- Beta
- 0.71
- P/E (TTM)
- -0.6
- EPS (TTM)
- -$1.08
Volume 18.56M
Average 0.44M
ATLN Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Atlantic International Corp.NASDAQ: ATLN
Cash & Equivalents · Q4 FY2025 · quarter ended Dec 2025
Cash & equivalents falls 88.0% from a year ago
Cash & equivalents stood at $81.13K at the end of Q4 FY2025, down 88.0% from a year earlier and down 2.7% from the prior quarter. Over 3 fiscal years it compounded at -66.6% a year.
Context
- Cash & equivalents amounted to 0.1% of total assets at the end of Q4 FY2025, down 0.5 pp from a year earlier.
- Cash & equivalents increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -88.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 81.13K USD
- Year-over-year change
- -88.0%
- 4-year CAGR
- -62.3%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 81.13K | -88.0% |
| FY2024 | 2024-12-31 | 678.68K | -49.8% |
| FY2023 | 2023-12-31 | 1.35M | -38.0% |
| FY2022 | 2022-12-31 | 2.18M | -45.7% |
| FY2021 | 2021-12-31 | 4.02M | — |
Cash & Equivalents vs competitors
How ATLN compares with its peers on the latest reported figures
- ATLN's Dec 2025 cash & equivalents of $81.13K is the lowest of the 8 companies compared; the peer median is $42.15M.
- Its year-over-year change of -88.0% is the lowest of 8, against a peer median of -3.4%.
- Cash & equivalents amounts to 0.1% of total assets for ATLN, versus a peer median of 32.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
AVRAnteris Technologies Global Corp. | Mar 2026 | $283.21M | +478.5% | +10.6% | 96.1% |
| Mar 2026 | $71.32M | +58.2% | +112.3% | 36.8% | |
| Mar 2026 | $56.02M | +16.8% | -39.7% | 32.0% | |
| Mar 2026 | $42.15M | -3.4% | -30.7% | 27.0% | |
IMDXInsight Molecular Diagnostics Inc. | Mar 2026 | $28.2M | -9.1% | -16.6% | 69.8% |
| Mar 2026 | $27.36M | -48.0% | +1.9% | 7.4% | |
| Mar 2026 | $13.21M | -37.7% | -21.4% | 10.5% | |
ATLNAtlantic International Corp. | Dec 2025 | $81.13K | -88.0% | -66.6% | 0.1% |
| Peer median (excluding ATLN) | $42.15M | -3.4% | -16.6% | 32.0% | |
Competitors are the stored peer set for ATLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 4.02M | 2.18M | 1.35M | 678.68K | 81.13K |
| Short-term Investments | 5.93M | 4.04M | 0 | 0 | 0 |
| Net Receivables | 65.68K | 81.21K | 64.48M | 73.44M | 69.99M |
| Inventory | 224.16K | 165.85K | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 3.68M | 4.7M | 11.12M |
| Total Current Assets | 10.42M | 6.64M | 78.8M | 88.02M | 81.2M |
| Property, Plant & Equipment (Net) | 265.27K | 1.66M | 2.8M | 2.38M | 3.17M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 36.19M | 31.4M | 26.6M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 5.24M | 0 | 0 |
| Other Non-current Assets | 50.49K | 118.95K | 3.64M | 960.6K | 2.26M |
| Total Non-current Assets | 315.76K | 1.78M | 47.87M | 34.73M | 32.03M |
| Total Assets | 10.74M | 8.41M | 126.67M | 122.75M | 113.23M |
| Account Payables | 871.36K | 622.44K | 799.57K | 2.03M | 5.11M |
| Short-term Debt | 1.38M | 0 | 138.9M | 43.88M | 7.99M |
| Tax Payables | 0 | 0 | 0 | 13.91K | 1.16M |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 360.46K | 0 | 11.1M | 101.84M |
| Total Current Liabilities | 2.56M | 1.23M | 161.56M | 97.25M | 114.95M |
| Long-term Debt | 0 | 1.38M | 980.85K | 36.71M | 30.37M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 2.18M | 0 | 0 |
| Total Non-current Liabilities | 0 | 2.82M | 4.46M | 37.52M | 30.37M |
| Total Liabilities | 2.56M | 4.05M | 166.02M | 134.77M | 145.32M |
| Common Stock | 119 | 119 | 254 | 531 | 557 |
| Retained Earnings | (14.41M) | (18.51M) | (61.8M) | (135.48M) | (194.91M) |
| Accumulated OCI | 0 | 22.45K | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 116 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 8.18M | 4.37M | (39.35M) | (12.02M) | (32.09M) |
| Total Debt | 1.38M | 2.93M | 142.62M | 82.72M | 38.36M |
| Net Debt | (2.64M) | 748.93K | 141.26M | 82.04M | 38.28M |
Atlantic International Corp.
NASDAQ:ATLN
Intrinsic Alpha fair value
Locked
Current Price
$0.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.